Mammalian prions: Tracking the infectious entities

Prion

Volumn 5, Issue 2, 2011, Pages 84-87

  Savistchenko, Jimmy ^a   Arellano Anaya, Zaira E ^a   Andréoletti, Olivier ^a   Vilette, Didier ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Aggregates; EST; Infectivity; Prions; PrP protein

Indexed keywords

PRION PROTEIN;

DEGENERATIVE DISEASE; NOTE; PATHOGENESIS; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN FOLDING;

ANIMALS; HUMANS; MAMMALS; PRION DISEASES; PRIONS; PROTEIN FOLDING;

MAMMALIAN PRION;

EID: 79959432177     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.5.2.16096     Document Type: Note

References (49)

1. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519-50. (Pubitemid 32695238)
2. Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89:1105-52.
3. Soto C, Castilla J. The controversial protein-only hypothesis of prion propagation. Nat Med 2004; 10:63-7.
4. Chesebro B. Prion protein and the transmissible spongiform encephalopathy diseases. Neuron 1999; 24:503-6.
5. Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043-4.
6. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83.
7. Diaz-Espinoza R, Soto C. Generation of prions in vitro and the protein-only hypothesis. Prion 2010; 4:53-9.
8. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309-11.
9. Prusiner SB. Chemistry and biology of prions. Biochemistry 1992; 31:12277-88. (Pubitemid 23163102)
10. Aguzzi A, Heikenwalder M, Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007; 8:552-61. (Pubitemid 46985384)
11. Merz PA, Somerville RA, Wisniewski HM, Iqbal K. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol (Berl) 1981; 54:63-74. (Pubitemid 11047598)
12. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35:349-58. (Pubitemid 14202913)
13. McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, Serban A, et al. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 1991; 65:1340-51.
14. Sc in vivo. J Biol Chem 2007; 282:35878-86. (Pubitemid 350277109)
15. Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997; 275:402-5. (Pubitemid 27051621)
16. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, et al. The Physical Relationship between Infectivity and Prion Protein Aggregates Is Strain-Dependent. PLoS Pathog 2010; 6:1000859.
17. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157-65. (Pubitemid 28468829)
18. Parchi P, Cescatti M, Notari S, Schulz-Schaeffer WJ, Capellari S, Giese A, et al. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 2010; 133:3030-42.
19. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010; 327:869-72.
20. Vilette D. Cell models of prion infection. Vet Res 2008; 39:10.
21. Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, Lehmann S, et al. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA 2001; 98:4055-9. (Pubitemid 32249897)
22. Cronier S, Laude H, Peyrin JM. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc Natl Acad Sci USA 2004; 101:12271-6. (Pubitemid 39145433)
23. Arellano-Anaya ZA. A Simple, Versatile and Sensitive Cell-Based Assay for Prions from Various Species. PLoS One 2011; In press.
24. Arellano Anaya ZE, Savistchenko J, Massonneau V, Lacroux C, Andreoletti O, Vilette D. Recovery of small infectious PrPres aggregates from prion-infected cultured cells. J Biol Chem 2011; 86:8141-8.
25. Courageot MP, Daude N, Nonno R, Paquet S, Di Bari MA, Le Dur A, et al. A cell line infectible by prion strains from different species. J Gen Virol 2008; 89:341-7.
26. Gabizon R, McKinley MP, Prusiner SB. Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 1987; 84:4017-21. (Pubitemid 17090866)
27. Manousis T, Verghese-Nikolakaki S, Keyes P, Sachsamanoglou M, Dawson M, Papadopoulos O, et al. Characterization of the murine BSE infectious agent. J Gen Virol 2000; 81:1615-20. (Pubitemid 30342910)
28. Riesner D, Kellings K, Post K, Wille H, Serban H, Groth D, et al. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity. J Virol 1996; 70:1714-22. (Pubitemid 26062931)
29. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257-61. (Pubitemid 41294488)
30. Lee S, Fernandez EJ, Good TA. Role of aggregation conditions in structure, stability and toxicity of intermediates in the Abeta fibril formation pathway. Protein Sci 2007; 16:723-32. (Pubitemid 46507001)
31. +]. Science 1995; 268:880-4.
32. Krammer C, Schatzl HM, Vorberg I. Prion-like propagation of cytosolic protein aggregates: insights from cell culture models. Prion 2009; 3:206-12.
33. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci USA2004; 101:9683-8.
34. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004; 16:415-21. (Pubitemid 38903148)
35. Fevrier B, Vilette D, Laude H, Raposo G. Exosomes: a bubble ride for prions? Traffic 2005; 6:10-7.
36. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, et al. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008; 416:297-305.
37. Deleault AM, Deleault NR, Harris BT, Rees JR, Supattapone S. The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol 2008; 89:2642-50.
38. D'Castro L, Wenborn A, Gros N, Joiner S, Cronier S, Collinge J, et al. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. PLoS One 2010; 5:15679.
39. Pirisinu L, Di Bari M, Marcon S, Vaccari G, DAgostino C, Fazzi P, et al. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrP. PLoS One 2010; 5:12723.
40. Thackray AM, Hopkins L, Bujdoso R. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay. Biochem J 2007; 401:475-83. (Pubitemid 46166430)
41. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41:12868-75. (Pubitemid 35192516)
42. Sc fraction. Biochemistry 2006; 45:15710-7. (Pubitemid 46032491)
43. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005; 102:3501-6.
44. Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO, et al. Protease-sensitive synthetic prions. PLoS Pathog 2010; 6:1000736.
45. Soto C, Satani N. The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 2010.
46. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6. (Pubitemid 350098981)
47. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540-2.
48. Solomon IH, Schepker JA, Harris DA. Prion neurotoxicity: insights from prion protein mutants. Curr Issues Mol Biol 2010; 12:51-61.
49. Caughey B, Lansbury PT. Protofibrils, pores, fibrils and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003; 26:267-98. (Pubitemid 37064935)